A Psychoeducational Intervention Supporting Patients With an Inherited

Status Suspended

Clinical Trial Summary

Inherited heart conditions (IHCs) can cause young sudden deaths due to a genetic trait that leads to a thickened heart muscle or abnormal heart rhythms. Relatives of an affected person have a 50% chance of inheriting IHCs and this is determined either through a blood test (predictive genetic test) and/or physical tests such as a heart tracing (electrocardiogram), scan (echocardiogram) and exercise test. When patients find out they are affected or are carriers for an IHC, they have numerous questions about medical management, prognosis, lifestyle; as well as experiencing stress and anxiety because of the impact on their health and risk to their family. Based on published studies and interviews, a psychoeducational intervention underpinned by Self-determination Theory was developed to support these patients An uncontrolled study to determine the feasibility of the intervention and outcome measures will be undertaken. Patients with a new IHC diagnosis or a carrier result aged 16 years and older will be recruited from outpatient clinics in London and will be receive the intervention consisting of a disease-specific information leaflet, a personalised lifestyle consideration guide and participation in a 1-hour group session facilitated by a cardiac genetic nurse. Outcome measures to look at degree of self-determination, autonomy support and competence; and heart-related anxiety will be collected at baseline and at 3 months post intervention. Clinical and socio-demographic data will be obtained from medical notes. The feasibility and acceptability of the intervention will be measured by assessment of the study procedures such as recruitment, retention and any adverse events. It is expected that there will be up to 4 consecutive group sessions and feedback from each session will be used to co-design and refine the intervention model for a definitive clinical trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cardiomyopathies
Inherited Cardiac Conduction Disorder

Clinical Trial Details

NCT number	NCT03602040
Study type	Interventional
Source	King's College London
Contact
Status	Suspended
Phase	N/A
Start date	June 2022
Completion date	June 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05428787` - Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing	N/A
Not yet recruiting	`NCT05567445` - Outcome of Cardiomyopathic Adults Admission in ICU.
Completed	`NCT02555527` - Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment	N/A
Completed	`NCT00371891` - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)	Phase 4
Recruiting	`NCT05552521` - Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
Recruiting	`NCT04166331` - Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion	Phase 3
Terminated	`NCT06331507` - Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch	N/A
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Recruiting	`NCT04695119` - Sepsis in the ICU-II
Completed	`NCT03228966` - Ped HIV - Echo Study: Kenya
Not yet recruiting	`NCT06348732` - Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings
Recruiting	`NCT05556369` - Genetic Characterization of Cardiomyopathies (POLICARDIOMIO2021)
Recruiting	`NCT04520646` - A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy	N/A
Not yet recruiting	`NCT03899298` - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions	Phase 1
Completed	`NCT04323852` - Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?	Phase 4
Completed	`NCT03527381` - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery	Phase 1/Phase 2
Withdrawn	`NCT02462213` - Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging	N/A
Active, not recruiting	`NCT00418041` - Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)	N/A
Not yet recruiting	`NCT06091475` - Therapy to Maintain Remission in Dilated Cardiomyopathy	N/A
Recruiting	`NCT03317964` - Genetic Basis of Pacing-induced Cardiomyopathy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Psychoeducational Intervention Supporting Patients With an Inherited Cardiac Condition — PISICC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms